Gilead Sciences, US3755581036

Gilead Sciences stock slips 0.7 percent ahead of the open

Published on 09/23/2026 at 07:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 22, 2026, Gilead Sciences stock stood at USD 149.56 on the Nasdaq after a 0.7 percent decline. The shares traded between USD 148.71 and USD 150.56, while the Nasdaq Composite rose 2.3 percent.

Photorealistischer Biotech-Campus von Gilead Sciences mit Glaslabor und Wissenschaftlern
Gilead Sciences Forschungscampus mit ISIN US3755581036 modernes Biopharma-Labor Kalifornien Glasfassade Wissenschaftler arbeiten, Illustration mit AI erstellt.

Gilead Sciences stock closed at USD 149.56 on the Nasdaq on September 22, 2026, down 0.7 percent. The decline contrasted with the Nasdaq Composite, which gained 2.3 percent to 27,122.09 on the same session.

September 22, 2026 in numbers

Gilead Sciences, Inc. (ISIN US3755581036, Nasdaq: GILD) opened at USD 150.56 and reached an intraday low of USD 148.71. The shares finished USD 1.00 below the opening price, providing a second quantified measure of the session.

At 3:53 p.m. ET, 111,305 shares had traded, according to the market data cited by AD HOC NEWS. The September 22 close was USD 7.73 below the reported 52-week high of USD 157.29, while the 52-week low stood at USD 108.46.

Dividend payment on September 29, 2026

Gilead Sciences is scheduled to pay a quarterly dividend of USD 0.82 per share on September 29, 2026. As MarketBeat reported, shareholders of record on September 15, 2026, were scheduled to receive the payment.

Disclaimer...

en | US3755581036 | GILEAD SCIENCES | boerse | 70163406 | bgmi